MAG appoints Jenny Claridge as director of sales

Medical Aesthetic Group is delighted to announce the appointment of Jenny Claridge as director of sales effective May 1, 2015.

Following an outstanding healthcare career at Johnson & Johnson spanning consumer products, surgery and vision care, Claridge joins Medical Aesthetics to head the sales and marketing team. At J & J, she worked in a range of sales and marketing positions, encompassing account management, European brand marketing, professional marketing and national sales leadership. More recently, she has held consultancy roles within optical training and medical regulatory affairs.

Having a strong interest in the growth of innovative medical aesthetics products, Jenny is looking forward to applying her experience and strong relationship skills to strengthen the position of Medical Aesthetics and play a key role in the launch of new and exciting products such as Fillerina the “no needle” HA filler, into the market. Claridge’s strong communication skills and professional marketing background will help Medical Aesthetics continue to build on over 15 years of excellent customer service and product innovation. With a brief to strengthen client contact and relationships, Clairdge will work with the existing sales and marketing teams to expand product knowledge, in clinic training and to introduce new products for existing and new clients.

David Gower, managing director of Medical Aesthetic Group, said, “This is perhaps the most exciting time for the group, which is experiencing incredible growth from its recent new product launches of V-soft lift, Fillerina and the enlargement of the unique Oxygenetix range. Long established lines such as Mene & Moy, Simildiet and Inno Aesthetics skincare continue to grow and the US brand DCL will return before the end of 2015 in revised presentation. We are delighted that Jenny is joining the team to lead them to even greater success.”